Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||-1.93%||69.07||1.0%||$465.79m|
|REGN||Regeneron Pharmaceuticals, Inc.||1.13%||618.11||2.7%||$392.67m|
|VRTX||Vertex Pharmaceuticals, Inc.||-0.10%||230.84||1.9%||$334.35m|
|SNSS||Sunesis Pharmaceuticals, Inc.||-4.00%||2.88||0.7%||$201.32m|
|EXAS||EXACT Sciences Corp.||-1.67%||76.13||17.9%||$160.64m|
|ARNA||Arena Pharmaceuticals, Inc.||-0.51%||91.51||13.7%||$138.71m|
|ALNY||Alnylam Pharmaceuticals, Inc.||-0.41%||138.62||8.2%||$131.51m|
|BBIO||BridgeBio Pharma, Inc.||-0.51%||11.70||0.0%||$104.26m|
AquaBounty Technologies, Inc. engages in the provision of land-based aquaculture services. It includes farming of aquatic organisms such as fish, shellfish, crustaceans, and aquatic plants. The firm focuses on salmon product, a bioengineered Atlantic salmon that can grow to market size faster than conventional farmed Atlantic salmon. The company was founded by Elliot Z. Entis and Garth L. Fletcher on December 17, 1991 and is headquartered in Maynard, MA.